Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Olaplex Holdings, Inc. - Common Stock (NQ: OLPX )

1.580 +0.040 (+2.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Olaplex Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
3 Reasons to Sell OLPX and 1 Stock to Buy Instead
Olaplex has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $1.55. The stock also fell short of the S&P 500’s 3.8% gain during that period. 
Via StockStory
Topics Stocks
Exposures US Equities
Q3 Rundown: Edgewell Personal Care (NYSE:EPC) Vs Other Personal Care Stocks
Looking back on personal care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Edgewell Personal Care (NYSE:EPC) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Personal Care Stocks Q3 Teardown: Olaplex (NASDAQ:OLPX) Vs The Rest
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including Olaplex (NASDAQ:OLPX) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
Exposures Economy
A Closer Look at 4 Analyst Recommendations For Olaplex Hldgs
Via Benzinga
Demystifying Olaplex Hldgs: Insights From 4 Analyst Reviews
Via Benzinga
Evaluating Olaplex Hldgs: Insights From 7 Financial Analysts
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's Intraday Session
Via Benzinga
Olaplex (NASDAQ:OLPX) Misses Q3 Revenue Estimates
Hair care company Olaplex (NASDAQ:OLPX) missed Wall Street’s revenue expectations in Q3 CY2024, with sales falling 3.6% year on year to $119.1 million. The company’s full-year revenue guidance of $410... 
Via StockStory
Olaplex (OLPX) To Report Earnings Tomorrow: Here Is What To Expect
Hair care company Olaplex (NASDAQ:OLPX) will be announcing earnings results tomorrow before the bell. Here’s what to look for. 
Via StockStory
Q2 Earnings Outperformers: Coty (NYSE:COTY) And The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at personal care stocks, starting with Coty... 
Via StockStory
Topics Economy
Exposures Economy
What 6 Analyst Ratings Have To Say About Olaplex Hldgs
Via Benzinga
Analyst Expectations For Olaplex Hldgs's Future
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Earnings Outlook For Olaplex Hldgs
Via Benzinga
Reflecting On Personal Care Stocks’ Q2 Earnings: e.l.f. (NYSE:ELF)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including e.l.f. (NYSE:ELF) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months
Michael Burry, the investor renowned for his prescient bet against the housing market before the 2008 financial crisis, has seen his recent wager on Chinese stocks pay significant dividends. 
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
Expert Ratings for Olaplex Hldgs
Via Benzinga
Why Shares of Olaplex Soared This Week
Should investors follow Olaplex's executive chairman and consider buying shares of their own? 
Via The Motley Fool
Zoom Video Posts Strong Q2 Results, Joins Peloton Interactive, Opera And Other Big Stocks Moving Higher On Thursday
Via Benzinga
'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio
Famed investor Michael Burry, known for his prescient bet against the housing market before the 2008 financial crisis, has made significant changes to his hedge fund's portfolio in the second quarter... 
Via Benzinga
OLPX Stock Earnings: Olaplex Hldgs Meets EPS, Beats Revenue for Q2 2024
OLPX stock results show that Olaplex Hldgs met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Shoals Technologies, Affirm Holdings, Apple And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
OLPX Stock Earnings: Olaplex Hldgs Meets EPS, Beats Revenue for Q1 2024
OLPX stock results show that Olaplex Hldgs met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Friday. Shares of Ermenegildo Zegna N.V. (NYSE: ZGN) fell sharply during Friday’s session as the company reported FY23... 
Via Benzinga
Topics Stocks
Exposures US Equities
Ulta Beauty Posts Upbeat Sales, Joins Elastic, Samsara And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones index gaining around 50 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday. 
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.